Valproate [valproic acid] and Etoposide for Patients with Progressive, Relapsed or Refractory Neuronal tumors and Brain Metastases, Phase Ib clinical trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Etoposide; Valproic acid
- Indications Brain metastases; Neuroectodermal tumours
- Focus Adverse reactions
- 19 Sep 2012 Biomarkers information updated
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2011 Planned end date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.